1. Home
  2. GRF vs NEPH Comparison

GRF vs NEPH Comparison

Compare GRF & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRF
  • NEPH
  • Stock Information
  • Founded
  • GRF 1989
  • NEPH 1997
  • Country
  • GRF United States
  • NEPH United States
  • Employees
  • GRF N/A
  • NEPH N/A
  • Industry
  • GRF Finance/Investors Services
  • NEPH Medical/Dental Instruments
  • Sector
  • GRF Finance
  • NEPH Health Care
  • Exchange
  • GRF Nasdaq
  • NEPH Nasdaq
  • Market Cap
  • GRF 42.6M
  • NEPH 45.3M
  • IPO Year
  • GRF N/A
  • NEPH 2004
  • Fundamental
  • Price
  • GRF $10.62
  • NEPH $5.71
  • Analyst Decision
  • GRF
  • NEPH Strong Buy
  • Analyst Count
  • GRF 0
  • NEPH 2
  • Target Price
  • GRF N/A
  • NEPH $5.50
  • AVG Volume (30 Days)
  • GRF 3.0K
  • NEPH 66.1K
  • Earning Date
  • GRF 01-01-0001
  • NEPH 11-06-2025
  • Dividend Yield
  • GRF 3.70%
  • NEPH N/A
  • EPS Growth
  • GRF N/A
  • NEPH N/A
  • EPS
  • GRF 1.16
  • NEPH 0.12
  • Revenue
  • GRF N/A
  • NEPH $16,684,000.00
  • Revenue This Year
  • GRF N/A
  • NEPH $24.38
  • Revenue Next Year
  • GRF N/A
  • NEPH $10.16
  • P/E Ratio
  • GRF $8.15
  • NEPH $47.49
  • Revenue Growth
  • GRF N/A
  • NEPH 21.16
  • 52 Week Low
  • GRF $7.93
  • NEPH $1.36
  • 52 Week High
  • GRF $10.19
  • NEPH $5.94
  • Technical
  • Relative Strength Index (RSI)
  • GRF 54.48
  • NEPH 76.00
  • Support Level
  • GRF $10.51
  • NEPH $4.52
  • Resistance Level
  • GRF $10.72
  • NEPH $4.89
  • Average True Range (ATR)
  • GRF 0.14
  • NEPH 0.34
  • MACD
  • GRF -0.02
  • NEPH 0.12
  • Stochastic Oscillator
  • GRF 36.38
  • NEPH 87.01

About GRF Eagle Capital Growth Fund Inc.

Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: